Chimeric Antigen Receptor T-cell Therapy

Prohibiting health insurers and health maintenance organizations issuing, delivering, or renewing certain policies or contracts from refusing to contract with or denying coverage for certain providers of chimeric antigen receptor T-cell therapy, etc.